Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arthritis & Rheumatism

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1529-0131(200008)43:8<1710::AID-ANR6>3.0.CO;2-YPMID 10943860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis

  2005cited by this paper
• Adenoviral Gene Transfer of a u-PA Receptor-binding Plasmin Inhibitor and Green Fluorescent Protein: Inhibition of Migration and Visualization of Expression

  2000cited by this paper
• Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model.

  1999cited by this paper
• Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice

  1998cited by this paper
• Immunohistochemical analysis of matrix proteolytic enzymes in the periprosthetic tissue in the patients with loosening prostheses.

  1998cited by this paper
• Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

  1998cited by this paper
• Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis.

  1998cited by this paper
• Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective.

  1997cited by this paper
• Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture.

  1997cited by this paper
• Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints

  1997cited by this paper
• Doxyclycline inhibits collagen synthesis by bovine chondrocytes cultured in alginate.

  1997cited by this paper
• Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions.

  1997cited by this paper
• Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.

  1996cited by this paper
• Inhibition of human leukocyte and porcine pancreatic elastase by homologues of bovine pancreatic trypsin inhibitor.

  1996cited by this paper
• Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors

  1996cited by this paper
• Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.

  1996cited by this paper
• The urokinase/urokinase-receptor system and cancer invasion.

  1995cited by this paper
• Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.

  1995cited by this paper
• Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads.

  1994cited by this paper
• Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts.

  1994cited by this paper
• A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice.

  1994cited by this paper
• Binding of bovine basic pancreatic trypsin inhibitor (Kunitz) as well as bovine and porcine pancreatic secretory trypsin inhibitor (Kazal) to human cathepsin G: a kinetic and thermodynamic study.

  1993cited by this paper
• A one‐step enzyme immunoassay for the determination of total tissue‐type plasminogen activator (t‐PA) antigen in plasma

  1992cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Human synovial fibroblasts produce urokinase-type plasminogen activator.

  1986cited by this paper
• Plasmin degradation of cartilage proteoglycan.

  1984cited by this paper
• Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay.

  1984cited by this paper
• Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.

  1977cited by this paper

• The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives

  2023cites this paper
• Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

  2020cites this paper
• Synovial fibroblasts and articular tissue remodelling: Role and mechanisms.

  2020cites this paper
• uPA/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action

  2018cites this paper
• Gene Therapy in the Treatment of Knee Disorders

  2012cites this paper
• Innate Mechanisms of Synovitis – Fibrin Deposits Contribute to Invasion

  2012cites this paper
• Use of infliximab in the treatment of peripheral ulcerative keratitis in Crohn disease.

  2011cites this paper
• Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models

  2010cites this paper
• Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

  2009cites this paper
• A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study

  2009cites this paper
• A suppressive effect of prostaglandin E 2 on the expression of SERPINE1 /plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study

  2009cites this paper
• A suppressive effect of prostaglandin E 2 on the expression of SERPINE1 /plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study

  2009cites this paper
• Emerging roles of serine proteinases in tissue turnover in arthritis.

  2008cites this paper
• Review Proteinases in the joint: clinical relevance of proteinases in joint

  2007cites this paper
• Proteinases in the joint: clinical relevance of proteinases in joint destruction

  2007cites this paper
• Comparison of Pancreas Juice Proteins from Cancer Versus Pancreatitis Using Quantitative Proteomic Analysis

  2007cites this paper
• [Molecular and cellular basis of joint destruction in rheumatoid arthritis].

  2006cites this paper
• Molekulare und zelluläre Grundlagen der Gelenkdestruktion bei rheumatoider Arthritis

  2006cites this paper
• Synovial fibroblasts: key players in rheumatoid arthritis.

  2006cites this paper
• Molecular and cellular basis of rheumatoid joint destruction.

  2006cites this paper
• Antisense strategies in degenerative joint diseases: sense or nonsense?

  2006cites this paper
• Technology Insight: gene transfer and the design of novel treatments for rheumatoid arthritis

  2006cites this paper
• The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

  2005cites this paper
• Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

  2005cites this paper
• Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts.

  2004cites this paper
• Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis

  2004cites this paper
• Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal models.

  2004cites this paper
• Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis

  2004cites this paper
• Gene targeting: Roadmap to future therapies

  2004cites this paper
• Novel aspects and new roles for the serine protease plasmin

  2004cites this paper
• Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.

  2004cites this paper
• Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease

  2004cites this paper
• Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal models.

  2004cites this paper
• Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3

  2003cites this paper
• Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts.

  2003cites this paper
• Gene transfer as a future therapy for rheumatoid arthritis

  2003cites this paper
• [Polymorphonuclear granulocytes in rheumatic tissue destruction VIII. Considerations on the inflammatory cartilage destruction in chronic arthritides in comparison with liver injuries by PMN's].

  2003cites this paper
• Neutrophile Granulozyten bei der rheumatischen Gewebszerstörung

  2003cites this paper
• No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study.

  2003cites this paper
• Möglichkeiten der Gentherapie

  2003cites this paper
• The SCID mouse model: novel therapeutic targets – lessons from gene transfer

  2003cites this paper
• Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.

  2002cites this paper
• Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis.

  2002cites this paper
• Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis

  2002cites this paper
• Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis

  2002cites this paper
• Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.

  2002cites this paper
• Synthesis of a Kunitz-Type Serine Proteinase Inhibitory Protein That Shares Homology with Bovine Pancreatic Trypsin Inhibitor by Ovine Intervertebral Disc Cells in Serum-Free Alginate Bead Culture

  2002cites this paper
• Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis.

  2002cites this paper
• Rolle der Zytokine bei der Progredienz der rheumatoiden Arthritis

  2002cites this paper
• Gene Targeting of Cytokines and the Mitogen-Activated Protein Kinase Pathways in Human Rheumatoid Synovium Using the Severe Combined Immunodeficiency Mouse Model

  2002cites this paper
• Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.

  2001cites this paper
• [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].

  2001cites this paper
• Recent developments in the pathogenesis of rheumatoid arthritis focusing on the role of synovial fibroblasts n Zusammenfassung

  2001cites this paper
• Gene therapy for rheumatoid arthritis.

  2001cites this paper
• T-cell vaccination: from basics to the clinic.

  2001cites this paper
• Animal Model Inflammation, Immune Reactivity, and Angiogenesis in a Severe Combined Immunodeficiency Model of Rheumatoid Arthritis

  2001cites this paper
• The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.

  2001cites this paper
• Designing novel therapeutic strategies for rheumatic diseases.

  2001cites this paper
• Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.

  2001cites this paper
• New developments in the urokinase-type plasminogen activator system

  2001cites this paper
• Lighting up cancer aggressiveness: targeting the urokinase plasminogen activator receptor for intraoperative optical imaging

  year unknowncites this paper